Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM72D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
mRNA | GAGE12E | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | GAGE2E | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | GAGE12H | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | GMPPB | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | TEX13B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | RP13-512J5.1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | C2orf47 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |